| Literature DB >> 27983610 |
Jing Zeng1, Miao Liu2, Lei Wu3, Jianhua Wang4, Shanshan Yang5, Yiyan Wang6, Yao Yao7, Bin Jiang8, Yao He9,10.
Abstract
Background: The primary objective of this study was to explore the association of hypertriglyceridemic waist (HTGW) phenotype with chronic kidney disease (CKD) and its sex difference in an urban Chinese elderly population.Entities:
Keywords: chronic kidney disease; cross-sectional study; hypertriglyceridemic waist phenotype
Mesh:
Substances:
Year: 2016 PMID: 27983610 PMCID: PMC5201374 DOI: 10.3390/ijerph13121233
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the participants in each phenotype group (n = 2102).
| Variables | NWNT | NWET | EWNT | HTGW | |
|---|---|---|---|---|---|
| ( | ( | ( | ( | ||
| Age (years) | 71.81 ± 6.95 | 70.57 ± 6.67 | 71.87 ± 6.58 | 71.38 ± 6.24 | 0.116 |
| BMI (Kg/m2) | 21.91 ± 2.27 | 22.66 ± 2.24 | 25.92 ± 2.99 | 26.65 ± 3.03 | <0.001 |
| WC (cm) | 79.42 ± 6.38 | 80.46 ± 5.74 | 91.36 ± 7.16 | 92.77 ± 7.69 | <0.001 |
| SBP (mmHg) | 132.95 ± 17.37 | 135.29 ± 16.91 | 139.44 ± 19.91 | 143.74 ± 20.59 | <0.001 |
| DBP (mmHg) | 74.48 ± 7.61 | 76.60 ± 10.31 | 77.28 ± 7.55 | 79.76 ± 7.95 | <0.001 |
| TC (mmol/L) | 5.07 ± 0.91 | 5.74 ± 1.01 | 5.12 ± 0.97 | 5.51 ± 1.10 | <0.001 |
| TG (mmol/L) | 1.09 ± 0.32 | 2.48 ± 1.20 | 1.22 ± 0.29 | 2.55 ± 0.96 | <0.001 |
| HDL-C (mmol/L) | 1.62 ± 0.39 | 1.26 ± 0.31 | 1.47 ± 0.34 | 1.20 ± 0.27 | <0.001 |
| LDL-C (mmol/L) | 3.03 ± 0.78 | 3.68 ± 0.83 | 3.16 ± 0.78 | 3.45 ± 0.91 | <0.001 |
| FPG (mmol/L) | 5.72 ± 1.33 | 6.05 ± 1.40 | 5.99 ± 1.49 | 6.55 ± 2.04 | <0.001 |
| 2hPG (mmol/L) | 7.39 ± 2.54 | 8.10 ± 2.80 | 8.17 ± 2.93 | 9.25 ± 3.66 | <0.001 |
| eGFR(mL/min/1.73 m2) | 92.45 ± 21.01 | 93.40 ± 18.30 | 95.82 ± 22.49 | 93.02 ± 24.76 | 0.025 |
| Men | 290 (59.3) | 63 (47.7) | 308 (36.2) | 187 (29.7) | <0.001 |
| Married | 424 (86.7) | 110 (83.3) | 712 (83.6) | 528 (83.9) | 0.451 |
| Education (≥7 years) | 387 (79.1) | 119 (90.2) | 584 (68.5) | 432 (68.7) | <0.001 |
| Current smoking | 68 (13.9) | 16 (12.1) | 88 (10.3) | 59 (9.4) | 0.091 |
| Current drinking | 124 (25.4) | 23 (17.4) | 170 (20.0) | 108 (17.2) | 0.006 |
| Exercise (≥1 h/day) | 421 (86.1) | 118 (89.4) | 740 (86.9) | 525 (83.5) | 0.170 |
| Family history of CVD | 203 (41.5) | 56 (42.4) | 388 (45.5) | 300 (47.7) | 0.195 |
| Diabetes | 108 (22.1) | 36 (27.3) | 269 (31.6) | 261 (41.5) | <0.001 |
| Hypertension | 266 (54.4) | 86 (65.2) | 636 (74.6) | 524 (83.3) | <0.001 |
Data are ± S for continuous values or n (%) for category values. Abbreviations: NWNT = normal waist-normal triglycerides; NWET = normal waist-elevated triglycerides; EWNT = elevated waist-normal triglycerides; HTGW = hypertriglyceridemic waist; BMI = body mass index; WC = waist circumference; SBP = systolic blood pressure; DBP = diastolic blood pressure; TC = total cholesterol; TG = triglyceride; HDL-C = high-density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; FBG = fasting blood glucose; 2hPG = 2-h post glucose load; eGFR = glomerular filtration rate; CVD = cardiovascular disease.
Age- and sex-specific distribution of phenotypes in study participants (n = 2102).
| Subgroups | NWNT | NWET | EWNT | HTGW | |
|---|---|---|---|---|---|
| All ages | <0.001 | ||||
| Men ( | 290 (34.2) | 63 (7.4) | 308 (36.3) | 187 (22.1) | |
| Women ( | 199 (15.9) | 69 (5.5) | 544 (43.4) | 442 (35.2) | |
| Total | 489 (23.3) | 132 (6.3) | 852 (40.5) | 629 (29.9) | |
| <0.001 | 0.074 | 0.001 | <0.001 | ||
| 60–69 years | <0.001 | ||||
| Men ( | 93 (32.9) | 28 (9.9) | 91 (32.2) | 71 (25.1) | |
| Women ( | 105 (19.5) | 29 (5.4) | 231 (42.9) | 173 (32.2) | |
| Subtotal ( | 198 (24.1) | 57 (6.9) | 322 (39.2) | 244 (29.7) | |
| <0.001 | 0.016 | 0.003 | 0.035 | ||
| 70–79 years | <0.001 | ||||
| Men ( | 160 (35.6) | 30 (6.7) | 170 (37.8) | 90 (20.0) | |
| Women ( | 79 (12.4) | 36 (5.7) | 279 (43.8) | 243 (38.1) | |
| Subtotal ( | 239 (22.0) | 66 (6.1) | 449 (41.3) | 333 (30.6) | |
| <0.001 | 0.490 | 0.047 | <0.001 | ||
| ≥80 years | 0.172 | ||||
| Men ( | 37 (32.2) | 5 (4.3) | 47 (40.9) | 26 (22.6) | |
| Women ( | 15 (19.0) | 4 (5.1) | 34 (43.0) | 26 (32.9) | |
| Subtotal ( | 52 (26.8) | 9 (4.6) | 81 (41.8) | 52 (26.8) | |
| 0.042 | 1.00 | 0.763 | 0.111 |
Abbreviations: NWNT = normal waist-normal triglycerides, NWET = normal waist-elevated triglycerides, EWNT = elevated waist-normal triglycerides, HTGW = hypertriglyceridemic waist.
Prevalence of CKD and its components according to phenotype groups (n = 2102).
| Phenotype | Decreased Renal Function | Albuminuria | CKD | |
|---|---|---|---|---|
| Total | ||||
| NWNT | 489 | 21 (4.3) | 29 (5.9) | 44 (9.0) |
| NWET | 132 | 3 (2.3) | 3 (2.3) | 5 (3.8) |
| EWNT | 852 | 42 (4.9) | 77 (9.0) | 109 (12.8) |
| HTGW | 629 | 52 (8.3) | 69 (11.0) | 107 (17.0) |
| Subtotal | 2102 | 118 (5.6) | 178 (8.5) | 265 (12.6) |
| 0.004 | 0.001 | <0.001 | ||
| Men | ||||
| NWNT | 290 | 12 (4.1) | 15 (5.2) | 26 (9.0) |
| NWET | 63 | 3 (4.8) | 1 (1.6) | 3 (4.8) |
| EWNT | 308 | 28 (9.1) * | 30 (9.7) | 51 (16.6) * |
| HTGW | 187 | 18 (9.6) | 15 (8.0) | 29 (15.5) |
| Subtotal | 848 | 61 (7.2) | 61 (7.2) | 109 (12.9) |
| 0.038 | 0.028 | 0.006 | ||
| Women | ||||
| NWNT | 199 | 9 (4.5) | 14 (7.0) | 18 (9.0) |
| NWET | 69 | 0 (0.0) | 2 (2.9) | 2 (2.9) |
| EWNT | 544 | 14 (2.6) | 47 (8.6) | 58 (10.7) |
| HTGW | 442 | 34 (7.7) | 54 (12.2) | 78 (17.6) |
| Subtotal | 1254 | 57 (4.5) | 117 (9.3) | 156 (12.4) |
| <0.001 | 0.026 | <0.001 |
* Men vs. women, p < 0.05. Abbreviations: NWNT = normal waist-normal triglycerides, NWET = normal waist-elevated triglycerides, EWNT = elevated waist-normal triglycerides HTGW = hypertriglyceridemic waist.
Risk of CKD prevalence with the four phenotype groups (ORs and 95% CI).
| Phenotype | Model 1 | Model 2 | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Total | ||||||
| NWNT | 1.00 (Ref) | 1.00 (Ref) | ||||
| NWET | 0.44 | 0.17–1.14 | 0.090 | 0.39 | 0.15–1.01 | 0.051 |
| EWNT | 1.52 | 1.04–2.21 | 0.029 | 1.38 | 0.94–2.03 | 0.096 |
| HTGW | 2.26 | 1.55–3.31 | <0.001 | 1.95 | 1.32–2.88 | 0.001 |
| Men | ||||||
| NWNT | 1.00 (Ref) | 1.00 (Ref) | ||||
| NWET | 0.63 | 0.18–2.19 | 0.462 | 0.59 | 0.17–2.06 | 0.404 |
| EWNT | 1.94 | 1.16–3.26 | 0.012 | 1.73 | 1.02–2.92 | 0.041 |
| HTGW | 2.14 | 1.19–3.84 | 0.011 | 1.88 | 1.04–3.39 | 0.037 |
| Women | ||||||
| NWNT | 1.00 (Ref) | 1.00 (Ref) | ||||
| NWET | 0.29 | 0.07–1.30 | 0.107 | 0.24 | 0.05–1.07 | 0.062 |
| EWNT | 1.17 | 0.67–2.06 | 0.576 | 1.06 | 0.60–1.89 | 0.831 |
| HTGW | 2.10 | 1.22–3.64 | 0.008 | 1.66 | 0.94–2.94 | 0.080 |
Model 1 adjusted by age, sex, education, marital status, physical exercise, smoking, drinking, and family history of CVD. Model 2 additionally adjusted by diabetes and hypertension. Abbreviations: NWNT = normal waist-normal triglycerides; NWET = normal waist-elevated triglycerides; EWNT = elevated waist-normal triglycerides; HTGW = hypertriglyceridemic waist; CI = confidence interval; OR = odds ratio.